Largazin Syrup

About Largazin 25 mg/5 ml Syrup

Largazin Syrup is a chlorpromazine hydrochloride medicine in a 25 mg/5 ml strength, supplied by United Chemicals & Pharmaceuticals Ltd. It is used in mental health conditions such as schizophrenia, other psychoses, mania and hypomania, and as a short-term adjunct in anxiety with agitation or excitement.

There are 14 brands of Chlorpromazine Hydrochloride listed in Bangladesh. 8 of them have a lower unit price than Largazin. The lowest listed price is Opsonil 25 mg Tablet at ৳ 0.4 per unit.

What is Largazin 25 mg/5 ml Syrup?

Largazin Syrup is a liquid form of chlorpromazine hydrochloride, a neuroleptic medicine. It belongs to the anti-emetic group of drugs and works on the nervous system by blocking dopamine receptors. Doctors prescribe it for schizophrenia and other psychoses, particularly paranoid types, and for mania and hypomania. It is also used as a short-term adjunct in anxiety with psychomotor agitation, excitement, or violent and dangerously impulsive behaviour. The syrup comes in a 25 mg/5 ml strength in a 30 ml bottle. It is a prescription medicine, so the doctor decides whether it is suitable and what course to follow.

Uses of Largazin

Largazin Syrup is used for schizophrenia and other psychoses, especially paranoid types, and for mania and hypomania. It is also used short term, alongside other measures, in anxiety with psychomotor agitation, excitement, or violent and dangerously impulsive behaviour. The doctor decides whether the syrup is appropriate for a particular person and situation.

How to use Largazin

Largazin Syrup is taken by mouth as directed by the doctor. The doctor decides the dose and how long it is taken, based on the condition and the person's age and response. Do not change the amount or stop suddenly without medical advice. If a dose is missed, ask the doctor or pharmacist what to do. Follow the instructions given with the prescription.

Side effects of Largazin

Side effects reported with chlorpromazine or phenothiazines include low blood pressure on standing, ECG changes, skin reactions such as contact dermatitis and photosensitivity, raised prolactin levels, impaired temperature control, high blood sugar, dry mouth and constipation, urinary retention, and blood cell changes such as leucopenia and anaemia. Some reactions can be serious. Anyone who feels unwell or notices unusual symptoms while taking Largazin Syrup should contact the doctor promptly.

Safety and precautions

Largazin Syrup should not be used in circulatory collapse, CNS depression such as coma or drug intoxication, bone marrow depression, phaeochromocytoma, hepatic failure or active liver disease, or after a previous hypersensitivity reaction to phenothiazines. It generally should not be used in epilepsy, Parkinson's disease, hypoparathyroidism, myasthenia gravis or prostatic hypertrophy. Pregnancy is category C and the medicine is excreted in breast milk, so pregnant or breastfeeding women should ask the doctor first. The doctor should also be told about any liver, blood or heart problems and about all other medicines being taken.

Frequently asked questions

What is Largazin Syrup used for and what kind of medicine is it?

Largazin Syrup contains chlorpromazine hydrochloride, a neuroleptic from the anti-emetic drug group. It is used for schizophrenia and other psychoses, mania and hypomania, and short term as an adjunct in anxiety with agitation, excitement or dangerously impulsive behaviour. The doctor decides if it is suitable.

How should Largazin Syrup be taken?

It is taken by mouth. The doctor decides the dose, how often it is taken and for how long, based on the condition and the person's age and response. Follow the prescription exactly and ask the doctor or pharmacist before making any change or stopping it.

Which medicines may interact with Largazin Syrup?

Food, alcohol, benztropine and antacids can affect its absorption. Lithium and long-term barbiturates can increase its clearance. Tricyclic antidepressants, ciprofloxacin, fluvoxamine, oral contraceptives and vemurafenib can raise its levels. Tell the doctor or pharmacist about all medicines, including over-the-counter ones, before starting Largazin Syrup.

What is the price of Largazin Syrup?

The listed price is ৳ 16.00. Ask the pharmacist about the current price and availability, as prices can change.

Indications

Chlorpromazine is indicated in the following conditions:
  • Schizophrenia and other psychoses (especially paranoid), mania and hypomania.
  • In anxiety psychomotor agitation excitement, violent or dangerously impulsive behaviour. Chlorpromazine is used as an adjunct in the short-term management of these conditions.
  • ... Read more
Chlorpromazine is indicated in the following conditions:
  • Schizophrenia and other psychoses (especially paranoid), mania and hypomania.
  • In anxiety psychomotor agitation excitement, violent or dangerously impulsive behaviour. Chlorpromazine is used as an adjunct in the short-term management of these conditions.
  • Intractable hiccup.
  • Nausea and vomiting of terminal illness (where other medicines have failed or are not available).
  • Childhood schizophrenia and autism.

Pharmacology

Chlorpromazine is a neuroleptic that acts by blocking the postsynaptic dopamine receptor in the mesolimbic dopaminergic system and inhibits the release of hypothalamic and hypophyseal hormones. It has antiemetic, serotonin-blocking, and weak antihistaminic properties and slight ganglion-blocking activity.

Dosage & Administration

Schizophrenia, Psychoses, Anxiety and Agitation

Oral-
  • Adult: Initially 25 mg three times daily or 75 mg at bedtime increasing by daily amounts of 25 mg to an effective maintenance dose. This is usually in the range 75 to 300 mg daily, but some patients may require up to 1 g daily.
  • Children: Under 1 Year: Do not use unless need is life saving. 1-5 Years: 0.5 mg/kg bodyweight every 4 - 6 hours to a maximum recommended dose of 40 mg daily. 6-12 Years: A third to half the adult dose, to a maximum recommended dose of 75 mg daily.
  • Elderly: Start with a third to a half the usual adult dose with a more gradual increase in dosage.
Intramuscular-
  • Adult: For acute relief of symptoms 25 - 50 mg every 6-8 hours.
  • Children: Under 1 Year: Do not use unless need is life saving. 1-5 Years: 0.5 mg/kg bodyweight every 6 - 8 hours. Dosage is not advised to exceed 40 mg daily. 6-12 Years: 0.5 mg/kg bodyweight every 6-8 hours. Not to exceed 75 mg daily.
  • Elderly: Doses in the lower range for adults should be sufficient to control symptoms, i.e. 25 mg, 8 hourly.


Intractable Hiccup (Adult)

  • Oral: 25-50 mg three or four times daily.
  • Intramuscular: 25-50 mg every 6-8 hours.
  • Intravenous Infusion: If other routes of administration are inappropriate, give 25-50 mg in 500-1000 ml sodium chloride by slow intravenous infusion every 6-8 hours.


Nausea and Vomiting of Terminal Illness

Oral-
  • Adults: 10-25 mg every 4-6 hours.
  • Children: Under 1 Year: Do not use unless need is life saving. 1-5 Years: 0.5 mg/kg every 4 - 6 hours. Maximum daily dosage should not exceed 40 mg. 6-12 Years: 0.5 mg/kg every 4 - 6 hours. Maximum daily dosage should not exceed 75 mg.
  • Elderly: Initially a third to half the adult dose. The physician should then use their clinical judgement to obtain control.
Intramuscular-
  • Adults: 25 mg initially, then 25 - 50 mg every 3 - 4 hours until vomiting stops, then drug to be taken orally.
  • Children: Under 1 Year: Do not use unless need is life saving. 1-5 Years: 0.5 mg/kg 6 - 8 hourly. It is advised that maximum daily dosage should not exceed 40 mg. 6-12 Years: 0.5 mg/kg every 6 - 8 hours. It is advised that maximum daily dosage should not exceed 75 mg.

Interaction

Interactions resulting in decreased chlorpromazine levels: Food, alcohol and benztropine can reduce the absorption of chlorpromazine. Antacids can slow the absorption of chlorpromazine. Lithium and chronic administration of barbiturates can lead to increased clearance of chlorpromazine.

Interactions resulting in increased chlorpromazine levels: Tricyclic antidepressants decrease the clearance of chlorpromazine and may lead to increased serum levels. Administration of chlorpromazine with CYP1A2 inhibitors, in particular strong (such as ciprofloxacin and fluvoxamine) or moderate (such as oral contraceptives and vemurafenib) inhibitors leads to an increase in chlorpromazine plasma concentrations. Therefore, patients may experience any chlorpromazine dose-dependent adverse drug reaction.

Contraindications

Chlorpromazine should never be used in the following circumstances:
  • Circulatory collapse.
  • CNS depression, e.g. coma or drug intoxication.
  • Previous history of a hypersensitivity reaction (e.g. jaundice or blood dyscrasia) to phenothiazines, especially chlorpromazine itself, or to any of the excipients contained in the tablets or injection.
  • Bone marrow depression.
  • Phaeochromocytoma.
  • Hepatic failure or active hepatic disease.
  • Chlorpromazine Injection contains sodium metabisulfite and sodium sulfite and may cause allergic-type reactions including anaphylactic symptoms and asthmatic episodes in susceptible people.

Side Effects

The following adverse effects have been reported for chlorpromazine or phenothiazines in
general.
  • Cardiovascular: Postural hypotension, ECG Changes.
  • Dermatological
  • Contact dermatitis, photosensitivity, urticarial, maculopapular, petechial or oedematous reactions.
  • Endocrine: Elevated prolactin levels, impaired thermoregulation, hyperglycaemia, other hypothalamic effects.
  • Gastrointestinal: Dry mouth, constipation.
  • Immunological: Raised ANA titre, positive SLE cells.
  • Genitourinary: Urinary retention.
  • Haematological: Leucopenia, agranulocytosis, eosinophilia, hemolytic anaemia, aplastic anaemia, thrombocytopenic purpura and pancytopenia have been reported.

Pregnancy & Lactation

Pregnancy category C. Studies in animals by oral route have shown reproductive toxicity (dose-related embryo fetotoxicity: increased resorptions and dead foetuses). Increased incidence of malformations was observed in mice but only at doses inducing maternal mortality. There is inadequate animal data regarding reproductive toxicity with chlorpromazine by parenteral route. In humans, the teratogenic risk of chlorpromazine has not been evaluated. Different prospective epidemiological studies conducted with other phenothiazines have yielded contradictory results regarding teratogenic risk. Chlorpromazine has been found to be excreted in breast milk in variable amounts, therefore it is not recommended for nursing mothers unless the expected benefits outweigh any potential risk.

Precautions & Warnings

Chlorpromazine generally should not be used in epilepsy, Parkinson’s disease, hypoparathyroidism, myasthenia gravis and prostatic hypertrophy.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Chlorpromazine Hydrochloride

Other brands with the same generic name, cheapest first.

See all 14 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.